• 1. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. Alt-proteins: A promising future

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Coumaric acid esters

Introduction to 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) and its CAS No. 72943-88-5

The compound 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E), identified by the CAS number 72943-88-5, represents a fascinating molecule with significant potential in the field of pharmaceutical and biochemical research. This compound belongs to the class of esters derived from cinnamic acid, a well-known aromatic compound with diverse biological activities. The presence of an octadecyl group in its structure enhances its solubility and stability, making it a valuable candidate for various applications.

In recent years, there has been growing interest in the development of novel compounds that can modulate biological pathways involved in inflammation, cancer, and neurodegenerative diseases. The structural features of 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) make it a promising candidate for such investigations. Specifically, the hydroxyl group at the para position of the phenyl ring and the double bond in the (2E) configuration contribute to its unique chemical properties and biological interactions.

One of the most compelling aspects of this compound is its potential as an anti-inflammatory agent. Studies have shown that derivatives of cinnamic acid can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6. The octadecyl ester moiety not only improves the pharmacokinetic properties of the molecule but also enhances its ability to interact with cellular receptors involved in inflammatory responses. This has led to several preclinical studies exploring its efficacy in models of acute and chronic inflammation.

Furthermore, the compound has shown promise in cancer research. The hydroxyl group on the phenyl ring can participate in hydrogen bonding interactions with biological targets, potentially leading to the development of new chemotherapeutic agents. Preliminary studies have indicated that 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) can inhibit the growth of certain cancer cell lines by modulating key signaling pathways involved in cell proliferation and apoptosis. These findings have prompted further investigation into its mechanism of action and potential therapeutic applications.

Another area where this compound has garnered attention is in neurodegenerative diseases. The ability of cinnamic acid derivatives to cross the blood-brain barrier makes them attractive candidates for treating conditions such as Alzheimer's disease and Parkinson's disease. Research has suggested that compounds like 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) can protect against oxidative stress and neuroinflammation, two key pathological processes in these diseases. Ongoing studies are aimed at elucidating how this molecule interacts with neural cells and whether it can mitigate damage caused by neurodegenerative insults.

The synthesis of 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) is a complex process that requires careful optimization to ensure high yield and purity. Traditional synthetic routes often involve multi-step reactions including esterification and reduction steps. However, advances in catalytic methods have enabled more efficient synthesis strategies. For instance, enzymatic catalysis has been employed to introduce the hydroxyl group at the para position of the phenyl ring with high selectivity. Similarly, transition metal-catalyzed cross-coupling reactions have been utilized to form the double bond in the (2E) configuration.

In terms of analytical characterization, 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) is typically analyzed using techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and high-performance liquid chromatography (HPLC). These methods provide detailed information about its molecular structure and purity. NMR spectroscopy is particularly useful for confirming the presence of specific functional groups and their relative positions within the molecule. Mass spectrometry offers high sensitivity and specificity for detecting trace impurities that might affect its biological activity.

The pharmacological evaluation of 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) involves both in vitro and in vivo studies to assess its efficacy and safety profiles. In vitro assays are conducted using cell culture models to evaluate its effects on various biological targets such as enzymes and receptors. These studies help identify potential therapeutic applications and mechanisms of action. In vivo studies involve administering the compound to animal models to assess its pharmacokinetic properties and toxicological profile.

One notable feature of this compound is its stability under various conditions. The octadecyl ester moiety contributes to its resistance to hydrolysis and oxidation, making it suitable for long-term storage and transportation without significant degradation. This stability is crucial for pharmaceutical applications where shelf life is a critical factor.

The future prospects for 2-Propenoic acid, 3-(4-hydroxyphenyl)-, octadecyl ester, (2E) are promising given its diverse range of biological activities and favorable pharmacokinetic properties. Further research is needed to fully understand its mechanism of action and optimize its therapeutic potential. Collaborative efforts between academic researchers and industry scientists are essential for translating preclinical findings into clinical applications that can benefit patients suffering from various diseases.

• 69573-60-0(2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, octadecyl ester, (2E)-)
• 28593-92-2(Docosyl 3-(3,4-dihydroxyphenyl)acrylate)
• 3487-99-8(Pentyl cinnamate)
• 10032-08-3(Heptyl cinnamate)
• 2979-06-8(Ethyl 4-coumarate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)